InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
| Product | Citation | Year | Journal | Authors | Page |
|---|---|---|---|---|---|
| TLR4 agonist preparation - MPLA-SM | Investigation of the differential potentials of TLR agonists to elicit uveiti... | 2011 | J. Leukoc. Biol. | Allensworth J.J. et al. | DOI: 10.1189/jlb.0511249 |
| HEK-Blue™ Selection | EptC of Campylobacter jejuni mediates phenotypes involved in host interaction... | 2013 | Infect Immun. | Cullen T.W. et al. | DOI: 10.1128/IAI.01046-12 |
| LPS-PG (Lipopolysaccharide from P. gingivalis) | Porphyromonas gingivalis lipopolysaccharide induces pro-inflammatory adipokin... | 2017 | Mol Cell Endocrinol. | Le Sage F. et al. | DOI: 10.1016/j.mce.2017.02.022 |
| ODN 1826 - TLR9 ligand | Respiratory Syncytial Virus Infects Regulatory B Cells in Human Neonates via ... | 2017 | Immunity. | Zhivaki D. et al. | DOI: 10.1016/j.immuni.2017.01.010 |
| Normocin® - Antimicrobial Reagent | Pathogen-Mediated Inhibition of Anorexia Promotes Host Survival and Transmiss... | 2017 | Cell. | Rao S. et al. | DOI: 10.1016/j.cell.2017.01.006 |
| Human TLR1-9 Agonist kit | Interferon-gamma secretion is induced in IL-12 stimulated human NK cells by r... | 2011 | Innate Immunity | Lindgren A. et al. | DOI: 10.1177/1753425909357970 |
| 2'3'-cGAMP | Inherited STING-activating mutation underlies a familial inflammatory syndrom... | 2014 | J Clin Invest. | Jeremiah N. et al. | DOI: 10.1172/JCI79100 |
| C12-iE-DAP | The Mitochondrial Proteins NLRX1 and TUFM Form a Complex that Regulates Type ... | 2012 | Immunity | Lei Y. et al. | DOI: 10.1016/j.immuni.2012.03.025 |
| Alhydrogel® adjuvant 2% | Comparative efficacy and toxicity of two vaccine candidates against Sporothri... | 2017 | Vaccine. | Portuondo DL. et al. | DOI: 10.1016/j.vaccine.2017.05.046 |
| ssRNA41/LyoVec™ | Oligodeoxynucleotides stabilize Helios-expressing Foxp3+ human T regulatory c... | 2012 | Blood | Kim Y.C. et al., | DOI: 10.1182/blood-2011-09-377895 |
| Pam3CSK4 VacciGrade™ | Dual T cell- and B cell-intrinsic deficiency in humans with biallelic RLTPR m... | 2016 | J Exp Med. | Wang Y. et al. | DOI: 10.1084/jem.20160576 |
| Imiquimod VacciGrade™ (R837) | Combinatorial Delivery of Dual and Triple TLR Agonists via Polymeric Pathogen... | 2017 | Sci Rep. | Madan-Lala R. et al. | DOI: 10.1038/s41598-017-02804-y |
| TLR4-based adjuvant - MPLA-SM VacciGrade™ | Prophylactic Herpes Simplex Virus 2 (HSV-2) Vaccines Adjuvanted with Stable E... | 2017 | J Virol. | Hensel M.T. et al. | DOI: 10.1128/JVI.02257-16 |
| Alhydrogel® adjuvant 2% | Enhanced expression of PD-L1 and IFN-γ on dendritic cells is associated with ... | 2017 | Cytokine. | Gouveia A.C. et al. | DOI: 10.1016/j.cyto.2017.09.005 |
| 293/Control Cells | Cleaved/Associated TLR3 Represents the Primary Form of the Signaling Receptor. | 2013 | J Immunol. | Toscano F. et al. | DOI: 10.4049/jimmunol.1202173 |
| Pam3CSK4 VacciGrade™ | Nlrp12 mutation causes C57BL/6J strain-specific defect in neutrophil recruitm... | 2016 | Nat Commun. | Ulland T.K. et al. | DOI: 10.1038/ncomms13180 |
| Imiquimod VacciGrade™ (R837) | Early type I Interferon response induces upregulation of human β-defensin 1 d... | 2017 | PLoS One. | Corleis B. et al. | DOI: 10.1371/journal.pone.0173161 |
| TLR4-based adjuvant - MPLA-SM VacciGrade™ | Pathogen-mimicking vaccine delivery system designed with a bioactive polymer ... | 2017 | J Control Release. | Tummala H. et al. | DOI: 10.1016/j.jconrel.2017.06.026 |
| FLA-ST (Standard or Ultrapure) | Toll-like receptor mediated activation is possibly involved in immunoregulati... | 2017 | PLoS One. | Kiewiet M.B. et al. | DOI: 10.1371/journal.pone.0178191 |
| THP1-Dual™ Cells | Investigations on the molecular mode of action of the novel immunostimulator ... | 2017 | Mol Immunol. | Ilg T. | DOI: 10.1016/j.molimm.2017.07.013 |